CFGS
BIO icon

Concourse Financial Group Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Concourse Financial Group Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-497
Closed -$179K – 216
2024
Q4 		$179K Sell
497
-42
-8% -$14.3K 0.01% 764
2024
Q3 		$180K Buy
539
+2
+0.4% +$635 0.01% 748
2024
Q2 		$147K Buy
537
+84
+19% +$24.4K 0.01% 808
2024
Q1 		$157K Buy
453
+46
+11% +$15.1K 0.01% 766
2023
Q4 		$131K Sell
407
-9
-2% -$2.82K 0.01% 806
2023
Q3 		$149K Buy
416
+65
+19% +$25.1K 0.01% 716
2023
Q2 		$133K Buy
351
+39
+13% +$15.9K 0.01% 771
2023
Q1 		$149K Sell
312
-13
-4% -$6.09K 0.01% 737
2022
Q4 		$137K Buy
325
+7
+2% +$2.83K 0.01% 731
2022
Q3 		$133K Sell
318
-1
-0.3% -$499 0.01% 640
2022
Q2 		$158K Buy
319
+1
+0.3% +$521 0.01% 658
2022
Q1 		$179K Sell
318
-20
-6% -$12.1K 0.01% 666
2021
Q4 		$255K Buy
338
+41
+14% +$30.7K 0.01% 649
2021
Q3 		$222K Sell
297
-15
-5% -$11.2K 0.01% 686
2021
Q2 		$201K Sell
312
-9
-3% -$5.48K 0.01% 715
2021
Q1 		$183K Sell
321
-42
-12% -$24.9K 0.01% 713
2020
Q4 		$212K Sell
363
-19
-5% -$10.8K 0.02% 615
2020
Q3 		$197K Buy
382
+47
+14% +$23.8K 0.02% 552
2020
Q2 		$151K Sell
335
-5
-1% -$2.21K 0.01% 588
2020
Q1 		$119K Buy
+340
New +$125K 0.01% 602
2019
Q2 		– Sell
-48
Closed -$14.4K – 2257
2019
Q1 		$14K Sell
48
-119
-71% -$32.1K ﹤0.01% 1386
2018
Q4 		$38K Sell
167
-21
-11% -$5.63K ﹤0.01% 907
2018
Q3 		$59K Buy
+188
New +$58.4K 0.02% 552

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Concourse Financial Group Securities's BIO Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 497 shares — an estimated $179K sold.

Concourse Financial Group Securities first reported a position in BIO in Q3 2018 and held it in 23 quarters. The position peaked at $255K in Q4 2021. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 497 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $179K.
  • Concourse Financial Group Securities first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 23 quarters.
  • Concourse Financial Group Securities's Bio-Rad Laboratories Class A position peaked at $255K in Q4 2021.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.